Halilibrahim Ciftci

35PUBLICATIONS
87CO-AUTHORS
Biomolecular modelling and designCharacterisation of biological macromoleculesSeparation technologiesBiologically active moleculesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Aug 27, 2026
Structural and Computationally Driven Molecule Design in Drug Discovery: Current Advances and Future Perspectives.

|Aug 27, 2026
Design, Synthesis and Biological Evaluation of Novel Oleanolic Acid Derivatives as Potential Anti-Leukemic Agents.

|Jul 28, 2026
Production, purification, and crystallization of the recombinant HER2 tyrosine kinase domain (HER2-TKD).

|Jul 28, 2026
Discovery of a Novel 4,5-Dihydro-1H-pyrazole-1-carbothioamide Derivative with Cytotoxic, Apoptotic, and ABL1 Inhibitory Activities Against Chronic Myeloid Leukemia.

|Jun 26, 2026
Targeting ABL Tyrosine Kinase in Chronic Myeloid Leukemia: Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Thiazolone Derivatives.

|Mar 28, 2026
Design, Synthesis, and Biological Evaluation of N,N-Diphenylaniline-Based Derivatives as Antiproliferative Agents and ABL TK Inhibitors Against CML.

Belgin Sever, Halilibrahim Ciftci

Pageof 6

Frequent Collaborators

24 joint publications

Belgin Sever

16 joint publications

Mikako Fujita

13 joint publications

Hasan DeMirci

9 joint publications

Mohamed O Radwan